Prix

The Fondo Elena Moroni for Oncology

is pleased to announce that the

Award Ceremony

for

The Enrico Anglesio Prize 2024

will take place on the 15th of November 2024 at 1 p.m. (Central European Time)

The audience can follow the ceremony at this link:

https://us06web.zoom.us/j/83122418215

Panellists will be invited to join the Award Ceremony by email

In addition to the Enrico Anglesio Prize offered by the Fondo Elena Moroni, two satellite Prizes will be awarded:

The Elvo Tempia Prize (offered by the Tempia Foundation) for the youngest best competitor after the absolute winner, and;

The Harald zur Hausen Prize for the best competitor of a Low-Middle Income Country

A NEW SPECIAL PRIZE FOR LMIC’s COMPETITORS

Starting from the 2024 edition, a new Special Prize has been established within the EAP System and intended for competitors from LMICs. It replaces the Sharon Whelan Special Prize, and it is dedicated to the memory of Professor Harald zur Hausen (1936 – 2023), Nobel Prize laureate for medicine in 2008

The HARALD zur HAUSEN SPECIAL PRIZE FOR LMIC’s COMPETITORS

Dr. Roberto Zanetti, FEM President, introduces the dedicatee of the new Special Prize

» I met Professor zur Hausen in Geneva in 2006 at a meeting of the Board of Directors of the UICC, Union for International Cancer Control, to which I was freshly elected, and that zur Hausen attended as the Editor in Chief of the International Journal of Cancer, the official journal of the UICC. That meeting happened a couple of years before zur Hausen was awarded the Nobel Prize, and some years after the appearance of the papers by Nubia Munoz and colleagues providing the final epidemiological demonstration that HPV infection is the cause of cervical cancer. During the meeting, Professor zur Hausen shortly reported about the IJC, and I have a precise memory of the clarity of his summary and the modesty of his attitude. Who was this man, and why short later he was he awarded the Nobel Prize? «

HARALD zur HAUSEN, 1936 – 2023

» Against the prevailing view during the 1970s, Harald zur Hausen postulated a role for human papillomavirus (HPV) in cervical cancer. He assumed that the tumour cells if they contained an oncologic virus, should harbour viral DNA integrated into their genomes. The HPV genes promoting cell proliferation should therefore be detectable by specifically searching tumour cells for such viral DNA. Harald zur Hausen pursued this idea over 10 years by searching for different HPV types, a search made difficult by the fact that only parts of the viral DNA were integrated into the host genome. He found novel HPV-DNA in cervix cancer biopsies and then discovered the new, tumorigenic HPV 16 type in 1983. In 1984 he cloned HPV 16 and 18 from patients with cervical cancer. The HPV types 16 and 18 were consistently found in about 70% of cervical cancer biopsies throughout the world.

The global public health burden attributable to HPV is considerable. More than 5% of all cancers worldwide are caused by persistent infection with this virus. Infection by HPV is the most common sexually transmitted agent, afflicting 50-80 % of the population. Of the more than 100 HPV types known, about 40 infect the genital tract and 15 of these put women at high risk for cervical cancer. In addition, HPV is found in some vulval, penile, oral and other cancers. HPV can be detected in 99,7% of women with histologically confirmed cervical cancer, afflicting some 500.000 women per year.

Harald zur Hausen demonstrated novel properties of HPV that led to an understanding of mechanisms for papillomavirus-induced carcinogenesis and the predisposing factors for viral persistence and cellular transformation. He made HPV 16 and 18 available to the scientific community. Vaccines were ultimately developed that provide > 95% protection from infection by the high-risk HPV 16 and 18 types. The vaccines may also reduce the need for surgery and the global burden of cervical cancer. » *

* from the Nobel Prize official website

Harald zur Hausen was born in 1936 in Gersenkirchen. He graduated in medicine in 1960 and started a career as a virologist. From 1983 to 2003 he chaired the Scientific Board of the German Cancer Institute, the DKFZ. He passed away in Heidelberg in March 2023.

The Winners of the Enrico Anglesio Prize 2023

The Enrico Anglesio Prize. Offered by the Fondo Elena Moroni, Turin, Italy. This prize goes to the best absolute scoring.

Here, in the linked video, a profile of Enrico Anglesio and the history the Prize from its definition and through the first 17 years: https://youtu.be/b5XZok-m50o

The Enrico Anglesio Prize

Enrico Anglesio (1908 – 2003)

Graduated in medicine in 1933, was a pioneer of modern oncology and chemotherapy in Italy. He contributed to research on lymphomas and founded one of the first Cancer Registries in the Southern European region, directing the coordination bodies of descriptive epidemiology. Enrico Anglesio had an active role in the UICC and was National Councillor and President of the Turin branch of the Italian League Against Cancer. He wrote several scientific publications, a digest of practical oncology and a brief history of oncology.

The Enrico Anglesio Prize 2023
Offered by the Fondo Elena Moroni

went to:

Alice Bernasconi, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy for her work on:
« Artificial Intelligence and Cancer Registry Data to predict Rare Events in Cancer Survivors »

The Elvo Tempia Special Prize. Offered by the Fondazione Tempia, Biella, Italy. The Prize goes to the youngest best scoring candidate in the first third of the ranking after the absolute winner.

The Elvo Tempia Special Prize

Elvo Tempia Valenta (1920 – 2004)

A young men during World War II, Mr Tempia joined the Italian patriotic troops that flanked the Allied armies in fighting the Nazis.
After the end of the war, he committed himself as a local politician and trade union leader. His long political and civil engagement culminated with the election as a member of the Italian National Parliament.
A family tragedy that happened during the eighties, the death due to cancer of a young son, stimulated Mr Tempia to establish The Fondo Edo Tempia, an advocacy organization based in Biella, Piedmont. The organization rapidly expanded as one of the largest in its country, with activities in health education, in primary cancer prevention and screening, and in assuring support to research laboratories and hospital departments.

The Elvo Tempia Special Prize 2023
Offered by the Tempia Foundation

went to:

Giulia Capitoli, Bicocca, Bioinformatics Biostatistics and Bioimaging Center, University of Milano-Bicocca, Milan, Italy for her work:
« Complete Blood Count Test in children and adolescent with Trisomy 21: definition of syndrome-specific reference intervals to detect evolution into onco-hematologic pathology »

The Sharon Whelan Special Prize. Offered by the International Association of Cancer registries, Lyon, France. This prize goes to the best scoring candidate coming from a Low-Middle Income Country

The Sharon Whelan Special Prize

Sharon L Whelan (1948 – 2016)

Sharon Whelan joined the staff of the Descriptive Epidemiology Unit at the International Agency for Research on Cancer few years after the establishment of that Institution in Lyon. There she spent her whole career, in the position of research assistant. Sharon’s main tasks have been two.
First, she was, beside the chief of the Unit, the person behind the planning, the collection of the data, and the editing of the well known international compendium Cancer Incidence in Five Continents.
Second, she assured for decades the organization of the activities of the International Association of Cancer Registries, the IACR, whose office is hosted at the IARC premise in Lyon. After retiring from the Agency, Sharon remained active with the Association, and in particular she authored the first contribution on its history, a long journal article appeared on the Asian Pacific Journal of Cancer Prevention

The Sharon Whelan Special Prize 2023
Offered by the International Association of Cancer Registries

went to:

Adriana Valdemar-Jiménez, Instituto Nacional de Cancerologia, Bogota, Colombia for her work:
« Factors associated with Loneliness in Colombian Cancer Patients »

SPECIAL WAIVER: The five best competitors in the category Methods & Originality have been granted a waiver to publish their articles free of charge in a Special issue of Cancers.

https://www.mdpi.com/journal/cancers/about

The SPECIAL WAIVER PRIZE 2023

went to:

Alice Bernasconi, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy:
« Artificial Intelligence and Cancer Registry Data to predict Rare Events in Cancer Survivors

Giulia Capitoli, Bicocca, Bioinformatics Biostatistics and Bioimaging Center, University of Milano-Bicocca, Milan, Italy: « Complete Blood Count Test in children and adolescent with Trisomy 21: definition of syndrome-specific reference intervals to detect evolution into onco-hematologic pathology »

Dafina Petrova, Andalusian School of Public Health – Cancer Registry of Granada, Spain: « Socio-economic inequalities in adherence to clinical practice guidelines for breast cancer diagnosis and treatment: using registry data to evaluate equity in cancer care »

Laura Schumann, Insitute of Socialmedicine and Epidemiology, University of Luebeck, Germany: « Lead-Time Corrected Effect on Breast Cancer Survival in Germany by Mode of Detection »

Karianne Svendsen, The Cancer Registry of Norway, Oslo, Norway: « How did Breast Cancer Patients fare during and after the Covid-19 pandemic compared to controls? »

Results of the past editions

IACR Round 2022

Enrico Anglesio Prize

Mojca Birk, Institute of Oncology Ljubljana, Slovenia: « Impact of Indoor Radon exposure on Lung Cancer Incidence in Slovenia«

Elvo Tempia Special Prize

Irmina Maria Michalek, Polish National Cancer Registry, Poland: « Risk of suicidal death in cancer patients aged 75 years and older in Poland, 2009-2019«

Sharon Whelan Special Prize

Thilagavathi Ramamoorthy, Indian Council of Medical Research – National Centre for Disease Informatics and Research, Bengaluru, India: « Utilization and adherence to clinical practice guidelines in cancer care: A study among physicians from Hospital Based Cancer Registries in India«

Here are the recorded videos of the year 2022 Award Ceremony
and Finalists’ Video Presentations

IACR Round 2021

Enrico Anglesio Prize

Marissa Corine van Maaren, Comprehensive Cancer Organisation (IKNL), The Netherlands: “Socioeconomic inequalities in young breast cancer patients: jointly modelling recurrences
and mortality using registry data”

Elvo Tempia Special Prize

Federica Zamagni, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS Epidemiology Unit and Emilia-Romagna Cancer Registry, section of Romagna University, Italy : “Decreasing thickness and enhanced therapy have both contributed to the 2010s increase in survival from melanoma in Italy”

Sharon Whelan Special Prize

Rym Mallekh, National Institute of Health, Tunisia, for her work:
“Burden of cancer attributable to excess body weight in Tunisia in 2019“

Here are the recorded videos of the year 2021 Award Ceremony
and Finalists’ Video Presentations

IACR Round 2020

Enrico Anglesio Prize

Diana R. Withrow, National Cancer Institute, Bethesda, USA: “Trends in non-malignant brain tumors incidence by source of diagnosis in USA, 2004-17”

Elvo Tempia Special Prize

Christiane Rudolph, University of Lubeck, Germany: “Breast cancer survival in German-Danish border regions”

Sharon Whelan Special Prize

Wilmer Tarupi, UTE University, Quito, Ecuador: “Educational inequalities in gastric cancer incidence and mortality, Quito 1996-2015”

Here are the recorded videos of the year 2020 Award Ceremony
and Finalists’ Video Presentations

Le vainqueur de 2019

Tour IACR

Le Prix Enrico Anglesio a été assigné à Vancouver (Canada) le 13 Juin 2019 à Quinn Ostrom de Houston (Texas) pour la présentation de l’étude « Relative survival after diagnosis with a primary brain or other CNS tumor in the National Program of Cancer Registries, 2001-2014 ».
Cette étude a été par la suite publiée dans la revue « Relative survival after diagnosis with a primary brain or other central nervous system tumor in the National Program of Cancer Registries, 2004 to 2014« .

Le vainqueur de 2018

Tour IACR

Le Prix Enrico Anglesio a été assigné à Arequipa (Perou) le 15 Novembre 2018 à Keiu Paapsi de Tallin (Estonia) pour la présentation de l’étude « Population based survival trends in childhood cancer in Estonia, 1970–2014 ».

Le vainqueur de 2017

Tour IACR

Le Prix Enrico Anglesio a été assigné à Utrecht (Pays Bas) le 19 Octobre 2017 à Simone Versteeg de Utrecht (Pays Bas) pour la présentation de l’étude « Centralisation of cancer surgery and the impact on patients’ travel burden ».

Cette étude a été par la suite publiée dans la revue Health Policy « Centralisation of cancer surgery and the impact on patients’ travel burden », et donc le prix a été doublé.

Le vainqueur de 2016

Tour IACR

ILe Prix Enrico Anglesio a été assigné à Marrakesh (Maroc) le 21 Octobre 2016 à Lidia Sacchetto de Turin (Italie) pour la présentation de l’étude « In situ, thin and thick melanoma in Europe: how and where are they increasing? ».

Cette étude a été par la suite publiée dans la revue European Journal of Cancer avec le titre « Trends in incidence of thick, thin and in situ melanoma in Europe ».

Tour GRELL

Le Prix Enrico Anglesio a été assigné à Albi (France) le 6 Mai 2016 à Daniel Jurado de Pasto (Colombie) pour la présentation de l’étude « Exploring social causal pathways for cervical cancer survival in low and middle income settings ».

Le vainqueur de 2015

Tour IACR

Le Prix Enrico Anglesio a été assigné à Mumbai (Inde) le 10 Octobre 2015 à Hanna Tervonen de Adelaide (Australie) pour la présentation de l’étude »Cancer survival and summary stage among Aboriginal and Torres Strait Islander people in NSW ».

Tour GRELL

Le Prix Enrico Anglesio a été assigné à Reus (Espagne) le 5 Mai 2015 à David Jegou de Bruxelles (Belgique) pour la présentation de l’étude « Trends in Incidence: a proposal to automatically check the linearity assumption for calculation of EAPC. »

Le vainqueur de 2014

Tour IACR

Le Prix Enrico Anglesio a été assigné à Ottawa (Canada) le 28 Juin 2014 à Clara Castro de Porto (Portugal) pour la présentation de l’étude « Predicting cancer incidence in the north of Portugal for the years 2013, 2015 and 2020 ».

Cette étude a été par la suite publiée dans la revue European Journal of Cancer Prevention avec le titre « Cancer incidence predictions in the North of Portugal: keeping population-based cancer registration up to date », et donc le prix a été doublé.

Tour GRELL

Le Prix Enrico Anglesio a été assigné à Genève (Suisse) le 30 Mai 2014 à Robin Schaffar de Genève pour la présentation de l’étude « Estimation of net survival in Geneva using both cause-specific and relative survival settings ».

Cette étude a été par la suite publiée dans la revue Cancer Epidemiology avec let titre « Cause-specific or relative survival setting to estimate population-based net survival from cancer? An empirical evaluation using women diagnosed with breast cancer in Geneva between 1981 and 1991 and followed for 20 years after diagnosis », Ayant cette publication respecté les termes de multiplication prévus par les règles du Prix, le vainqueur a obtenu le doublement du montant.

Le vainqueur de 2013

Tour IACR

Le Prix Enrico Anglesio a été assigné à Buenos Aires (Argentine) le 24 Octobre 2013 à Iman Meziane de Casablanca (Maroc) pour la présentation de l’étude: « The Moroccan Breast Cancer Registry (MBCR): Assessment of Breast Cancer Risk in Morocco ».

Tour GRELL

Le Prix Enrico Anglesio a été assigné à Siracuse (Italie) le 10 Mai 2013 à Morgane Mounier de Dijon (France) pour la présentation de l’étude « Changes in therapeutic management of follicular lymphoma: which impact on the excess mortality in the general population? ».

Le vainqueur de 2012

Tour IACR

Le Prix Enrico Anglesio a été assigné à Cork (Irlande) le 19 Septembre 2012 à Susan Spillane de Dublin (Irlande) pour la présentation de l’étude: « Use of the antidiabetic drug metformin and disease spread at diagnosis in colorectal cancer ».

Cette étude a par la suite été publiée dans la revue Cancer Epidemiology avec let titre « Metformin exposure and disseminated disease in patients with colorectal cancer ».

Tour GRELL

Le Prix Enrico Anglesio a été assigné à Porto (Portugal) le 18 Mai 2012 à Jérémie Jégu de Strasbourg (France) pour la présentation de l’étude: « Trends over three decades of the risk of second primary cancer among patients with head and neck cancer in Bas-Rhin ».

Cette étude a été par la suite publiée dans la revue Oral Oncology avec let titre « Trends over three decades of the risk of second primary cancer among patients with head and neck cancer ».

Ayant cette publication respecté les termes de multiplication prévus par les règles du Prix, le vainqueur a obtenu le doublement du montant.

Le vainqueur de 2011

Tour IACR

Le Prix Enrico Anglesio a été assigné à Balaclava (Mauritius), le 13 octobre 2011, à Mugi Wahidin, de Jakarta (Indonésie), pour la présentation de l’étude: « Method of Population-Based Cancer Registry in Indonesia ».

Tour GRELL

Le Prix Enrico Anglesio a été assigné à Caen, le 3 juin 2011, à Carole Pornet, de Caen (France), pour la présentation de l’étude: « Socio-geographic determinants for compliance to organised colorectal and breast cancer screening programmes « .

Le vainqueur de 2010

Tour IACR

Le Prix Enrico Anglesio a été assigné à Yokohama, le 12 octobre 2010, à Yuri Ito, de Osaka (Japon), pour la présentation de l’étude: « Trends in cure fraction for colorectal cancer in Osaka, Japan, between 1975 and 2000 ».

Tour GRELL

Le Prix Enrico Anglesio a été assigné à Toledo, le 14 mai 2010, à Bárbara Peleteiro, de Porto (Portugal), pour la présentation de l’étude: « Salt intake and Gastric cancer risk according to Helicobacter Pylori infection, tumour location and histological type« .

L’étude a été par la suite publiée dans le British Journal of Cancer (Br J Cancer. 2011 Jan 4;104(1):198-207) et le prix a été par ainsi triplé.

Les Lauréats du Tour GRELL des éditions précédentes

2009

Le Prix Enrico Anglesio a été assigné à Lugano, le 22 mai 2009, à Cyrille Delpierre, de Toulouse (France), pour la présentation de l’étude: « Surdiagnostic et surtraitement: Estimation de l’impact de l’utilisation du PSA comme dépistage du cancer prostatique dans la population Française ».

2008

L’année 2008 étant le centenaire de la naissance d’Enrico Anglesio, le prix a été exceptionnellement doublé et attribué ex-aequo à deux lauréats. La troisième édition du prix, attribué à Parme, a été gagnée par:

Claudia Allemani, Istituto Tumori, Milan, Italie, pour la présentation: “Breast cancer survival and alcohol consumption”. L’étude a été publiée dans le Journal Tumori avec le titre « Do pre-diagnostic drinking habits influence breast cancer survival? ».

Alessandra Spitale, Registre des Tumeurs du Tessin, Suisse, pour la présentation: « Neo-adjuvant radiotherapy in locally advanced rectal cancers improves survival: comparison between clinical trials findings and population-based observation. An analysis of Ticino cancer registry (south of Switzerland) », 1996-2003.

Les deux gagnantes ont reçu, tout comme le gagnant de l’édition précédente, un prix en argent et un superbe trophée souvenir, offert par Michèle et Pierre Band, Montréal.

2007

Le Prix Enrico Anglesio a été assigné à Montréal, le 19 mai 2007, à Jérémie Rudant, de Paris (France), pour la présentation de l’étude: “Household pesticides use and childhood hematopoietic malignancies: the ESCALE study (SFCE)”.

En plus du prix en argent, le lauréat de l’édition 2007 a reçu un superbe trophée souvenir, offert par l’organisateur de la réunion, Dr Pierre Band.

L’étude a été par la suite publiée dans le Journal Environmental Health Perspectives, avec le titre « Household exposure to pesticides and risk of childhood hematopoietic malignancies: The ESCALE study (SFCE) » et le prix a été par ainsi triplé.

2006

Le premier Prix Enrico Anglesio a été assigné à Palme de Majorque, le 26 mai 2006, à Fulvio Ricceri, de Turin (Italie), pour la présentation de l’étude: “Survival of Patients with Multiple Primary Tumours: an application to patients with a breast cancer form the Piedmont Cancer Registry”.

L’étude a été publiée dans le Journal Emerging Themes in Epidemiology avec le titre « Methodological issues in estimating survival in patients with multiple primary cancers: an application to women with breast cancer as a first tumour ».

Tour GRELL, participants par pays

Country of the Candidates	Edition
Country of the Candidates	Mallorca 2006	Montreal 2007	Parma 2008	Lugano 2009	Toledo 2010	Caen 2011	Porto 2012	Siracusa 2013	Genève 2014	Reus 2015	Albi 2016	Total	Winner
Belgium	0	0	0	0	0	0	0	0	0	1	1	2	1
Brazil	0	0	0	0	0	0	1	0	0	0	0	1	0
Colombia	0	0	0	0	0	0	1	0	0	1	1	3	1
France	0	1	1	2	0	3	2	2	3	2	3	19	5
Italy	4	2	2	1	1	0	2	5	2	0	3	22	2
Portugal	0	1	0	1	1	0	1	0	0	0	0	4	1
Romania	0	0	0	0	1	0	1	0	0	0	0	2	0
Spain	0	1	1	1	3	0	1	0	0	0	1	8	0
Switzerland	0	0	1	1	1	1	0	0	2	0	0	6	2
Total	4	5	5	6	7	4	9	7	7	4	9	67	12

Tour IACR

Edition	Winner	Other Competitors	Total number of participants
Yokohama 2010	Japan	Japan, Korea, Spain, The Netherlands, UK(2)	7
Mauritius 2011	Indonesia	Korea, Nigeria	3
Cork 2012	Ireland	Italy, Sweden, Switzerland, The Netherlands, UK	6
Buenos Aires 2013	Morocco	Brazil, Italy, Portugal	4
Ottawa 2014	Portugal	Canada(2), Colombia, USA	5
Mumbai 2015	Australia	Canada, India(3), Kenya(2), Nigeria, Slovakia	9
Marrakesh 2016	Italy	Argentina, France, Greece, Japan, Morocco, UK(3), USA	10
Utrecht 2017	The Netherlands	Belgium(2), France(2), Germany, Italy, Russia, The Netherlands(4)	12
Arequipa 2018	Estonia	Brazil, Colombia, Ecuador, Japan (2), France, South Africa	8
Vancouver 2019	USA	Brazil, Canada (2), Japan (2), Libya, Mauritius, Nepal, UK (2), USA (8)	19
2020 Virtual	USA	Colombia, Ecuador, Germany, Italy, Japan (2), Portugal, Spain, Switzerland (2), The Netherlands, Tunisia, UK (2), USA	15
2021 Virtual	The Netherlands	Australia, Canada, China, Colombia (2), France (2), Germany, India (3), Italy (4), Kenia, Poland, Portugal, Slovenia (2), Spain, Tanzania, Thailand, The Netherlands (9), Tunisia (2), USA	35
2022 Virtual	Slovenia	Belgium, Cina, France (2), Germany, India(2), Iran(2), Italy(4), Japan, Poland, Slovenia (2)	17
Granada 2023	Italy	Brazil, Colombia, Dominican Republic, Germany, Italy (2), Japan (2), Norway, Portugal, Rwanda, Slovenia, Spain, Switzerland	14